BILL · 2001–02 SESSION

HB 2022: Therapeutic substitution

Prohibiting therapeutic substitution.

Summary

  • Declares that "therapeutic substitution" means the dispensing of a therapeutic alternative or preferred drug instead of the original drug product prescribed, in accordance with either established written therapeutic interchange guidelines or protocols from the prescriber for the pharmacist to follow or as a result of a patient-specific consultation between the pharmacist and the prescriber.

From the Bill Digest (HB 2022), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedFeb 12, 2001
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Gary Alexander (R-20)
Introduced
February 12, 2001 in the House
Last action
January 14, 2002
Budget
Has a fiscal note

AN ACT Relating to prohibiting therapeutic substitution by the medical assistance administration;

Sponsors

Prime sponsor: Gary Alexander (R-20)

1 co-sponsor (0 Democrats, 1 Republican)

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. By resolution, reintroduced and retained in present status.
  3. First reading, referred to Health Care.

HB 2022 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page